Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers

This study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of BIA 10‐2474, a fatty acid amide hydrolase (FAAH) inhibitor, after first administration to healthy male and female participants. Participants (n = 116) were recruited into this phase I, double‐blind, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, José‐Francisco, Santos, Ana, Gama, Helena, Moser, Paul, Falcão, Amílcar, Pressman, Peter, Wallace Hayes, A., Soares‐da‐Silva, Patricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292215/
https://www.ncbi.nlm.nih.gov/pubmed/33998672
http://dx.doi.org/10.1002/cpt.2290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292215/
https://www.ncbi.nlm.nih.gov/pubmed/33998672
http://dx.doi.org/10.1002/cpt.2290

Ejemplares similares